期刊
PHARMACEUTICAL RESEARCH
卷 28, 期 6, 页码 1415-1421出版社
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-010-0327-z
关键词
kallikrein; plasma-activated; thrombin; tropoelastin
资金
- Australian Research Council
- National Health and Medical Research Council
- University of Sydney Medical Foundation
Purpose To modify blood-contacting stainless surfaces by covalently coating them with a serum-protease resistant form of tropoelastin (TE). To demonstrate that the modified TE retains an exposed, cell-adhesive C-terminus that persists in the presence of blood plasma proteases. Methods Recombinant human TE and a point mutant variant (R515A) of TE were labeled with (125)Iodine and immobilized on plasma-activated stainless steel (PAC) surfaces. Covalent attachment was confirmed using rigorous detergent washing. As kallikrein and thrombin dominate the serum degradation of tropoelastin, supraphysiological levels of these proteases were incubated with covalently bound TE and R515A, then assayed for protein levels by radioactivity detection. Persistence of the C-terminus was assessed by ELISA. Results TE was significantly retained covalently on PAC surfaces at 88 +/- 5% and 71 +/- 5% after treatment with kallikrein and thrombin, respectively. Retention of R515A was 100 +/- 1.3% and 87 +/- 2.3% after treatment with kallikrein and thrombin, respectively, representing significant improvements over TE. The functionally important C-terminus was cleaved in wild-type TE but retained by R515A. Conclusions Protein persists in the presence of human kallikrein and thrombin when covalently immobilized on metal substrata. R515A displays enhanced protease resistance and retains the C-terminus presenting a protein interface that is viable for blood-contacting applications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据